Thread by @sailorrooscout

Impressive data out of Malaysia. 14.5M participants. RECoVAM study shows full vaccination reduces the risk of infection by 88% and symptomatic disease by 86%.

AstraZeneca
•Against ICU Admission: 96%
•Against Death: 96%

Pfizer
•Against ICU Admission: 92%
•Against Death: 93%

Sinovac
•Against ICU Admission: 77%
•Against Death: 84%

Overall, the COVID-19 Vaccines cut ICU Admission risk by 83% and Deaths due to COVID-19 by 88% according to the study.

ICR Director Dr. Kalaiarasu said findings by the Real-World Evaluation of Covid-19 Vaccines Under the Malaysia National Covid-19 Immunization Program (RECoVaM) showed that the overall ICU rate amongst fully vaccinated individuals-14 days after the second vaccine dose in a

two-dose regime- stood at ONLY 0.0066%. This is equivalent to 953 ICU admissions in 14,500,984 fully vaccinated individuals tracked from April 1st to September 12th who received two doses of either Pfizer, AstraZeneca, or Sinovac. It was pointed out that 50.4% of the 953

breakthrough ICU admissions were age 60 or older and 88.6% had comorbidities. The RECoVaM study also found that breakthrough COVID-19 death rates were low among fully vaccinated individuals at 0.010% or 1,445 deaths OUT of 14.5 million individuals in the study.

Among the breakthrough mortality cases, 76.3% were age 60 or older, while 92% had comorbidities. Recipients of AstraZeneca were generally younger adults and recipients of Pfizer and Sinovac were generally older adults, including those most vulnerable.

This is data as of September 12th. The vaccines are highly effective in preventing severe disease, hospitalization, & death due to COVID-19 even in the face of the Delta variant which is currently the most prevalent variant in Malaysia.

Breakthrough ICU Rate: 0.0066% Breakthrough Death Rate: 0.010%
Dr. Kalaiarasu stated unvaccinated individuals are 11X MORE at risk of death due to the Delta variant. You can find this information here: codeblue.galencentre.org/2021/09/23/cov… and presentation here: